
usd jul pm et
summari provid health insur program servic primarili government-sponsor
health care program includ medicaid militari
price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
jul pm stock trade
total membership yoy
driven roughli million member ad
fide acquisit juli
well organ expans medicaid
marketplac busi importantli
maintain price medic cost disciplin
growth spurt annual medic
cost ratio june littl chang
prior-year period
oper revenu grew yoy
due share count dilut
fide acquisit growth lack
boost fide acquisit year
gone still expect robust earn
growth momentum build recent
medicaid contract win oregon new mexico
new hampshir iowa north carolina
marketplac retent rate
march announc plan acquir
competitor wellcar debt
equiti expect close deal
approv firm sharehold
approv regul creat far
largest medicaid manag care firm
histori value-ad acquisit
strateg cost contain invest
favor environ medicaid insur
think produc ep growth
well-abov peer-averag year ahead
purchas health net drove ep
compound-annual-growth-rate
think purchas fide close
wellcar wcg plan lead
robust growth well
state tax revenu grew above-norm
rate provid
tailwind medicaid premium growth
wcg acquisit also tremend
long-term valu potenti view
adjust medic cost ratio mcr
basi point wcg bring
wcg membership mcr
sever year creat signific valu
page detail
target price conserv
scenario estim normal ep
fulli integr wcg valuat
elev integr risk wcg
risk includ cut govern healthcar
budget sharp rise medic cost
success record expand health plan
new state govern program includ
medicaid medicar health insur marketplac
plan accomplish
leverag acquisit organ expans view
strategi posit also see risk
potenti state agenc feder govern
reduc program expenditur amid budget review
unexpect increas medic cost also take
substanti new execut risk plan
leverag acquisit competitor wellcar far
largest acquisit histori
oct ep estim base cfra oper earn
histor earn report compani report
cash dividend paid last year
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
execut vice-president
corpor overview centen corpor provid health insur relat health care
manag servic focu under-insur uninsur individu compani largest
membership popul government-sponsor program particularli medicaid
membership militari tricar program also offer privat individu small
busi health insur primarili health insur marketplac membership
market profil regulatori environ feder state govern share cost
medicaid program state administ feder guidelin state guarante
least qualifi medicaid expenditur match feder govern
state receiv greater match base formula consid state averag per capita
incom rel nation averag state handl administr medicaid
servic mani opt contract privat compani like insur resid and/or handl
administr health care servic
think best posit medicaid contract negoti state budget pressur
revenu shortfal recent environ therefor good one cnc medicaid busi
view total state tax revenu growth acceler growth
also set health insur marketplac privat insur sell health
insur plan standard feder govern individu small busi data
kaiser famili foundat indic marketplac enrol peak fell
period profit expand marketplac busi enter
state larg competitor like aetna pull back decemb
cnc marketplac enrol total membership market share
decemb
corpor strategi success track record expand membership
organ march acquir health net doubl
total membership led annual ep gain follow health net integr success
juli acquir new york-bas medicaid insur fide acquisit
increas cnc medicaid membership confid acquisit produc
substanti cost reduct organ growth opportun similar health net acquisit
order grow profit must also control growth health care cost member
sought achiev vertic integr steer member affili health care provid
possibl save cost versu third parti provid strateg invest health care
technolog compani also boost cnc margin long-term deliv health care
effici improv health risk price better data
acquisit along line includ full-servic specialti pharmaci strateg
invest health care manag primari care busi continu acquir
largest medicaid-focus physician group florida increas equiti stake interpreta
clinic genom data analysi busi acquir stake rxadvanc cloud-bas
pharmaci benefit manag technolog firm
wellcar acquisit march announc plan acquir rival medicaid insur wellcar
wcg billion debt newli issu equiti share deal approv sharehold
firm june expect close first half sharehold own
on-going busi equiti dilut deal also significantli increas interest expens
due estim billion new acquisit debt combin creat far
largest medicaid insur two firm million medicaid member decemb
compar million next largest competitor
increas scale allow gain cost synergi elimin duplic
oper think acquisit real valu potenti oper wellcar medicaid busi
alreadi establish medic cost effici strateg cost contain invest
detail pay recent year compani medic cost ratio mcr adjust
prior period reserv develop fell basi point far exceed mcr
improv larg manag care firm period also brought
adjust mcr basi point wcg think two year abl bring
wcg membership lower mcr creat valu combin firm far
outweigh debt equiti cost acquisit
addit note strong histori creat valu larg acquisit net
acquisit doubl medic membership led growth adjust pre-tax
incom per share first two year comparison wcg deal increas
medic membership think strong histori creat valu integr
previou acquisit play similar fashion wcg
financi trend oper revenu exclud regulatori tax fee invest incom driven
acquisit expans new state grew billion
compound annual growth rate compound-annual-growth-rate adjust pre-tax incom per share increas
compound-annual-growth-rate medic cost ratio mcr
estim leverag measur debt/ebita decemb
year earlier
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
lt debt capit
analysi stock current worth base
cfra proprietari quantit model suggest
fairli valu
figur base fiscal year-end price
growth rate averag
neutral sinc june technic indic
neutral
lt debt capit
return equiti
net life insur
balanc sheet data million usd
equival
return revenu
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
fundament outlook manag health
sub-industri next month
posit think largest driver
earn growth next year
cheaper gener drug vertic integr
help contain medic cost well
rise health plan membership price gain
driven healthi economi
banner year first-tim gener
drug fda approv record first
gener significantli
think set even higher record
first-tim gener alreadi approv
june versu period
first-tim gener price materi
brand-nam version help
contain medic cost manag health
firm throughout competit
older gener also intens recent
indic total fda gener
approv
mani compet
version gener enter market price
deflat becom norm past
sever year benefit payer
vertic integr health insur
pharmaci benefit manag pbm health
care provid also help contain medic
cost saw continu trend
insur integr pbm
manag care bought express script
pbm think move benefit manag
care firm integr allow
captur valu rebat pbm
negoti drug maker also
observ mani manag care firm buy
billion acquisit davita medic
group june think type vertic
integr help reduc medic cost
insur better control cost medic
procedur health plan member
strong domest economi also benefit
sub-industri year ahead
remain robust view yoy employ
gain averag fist six month
acceler averag growth
period job
growth favor full-tim worker
full-tim employ june
yoy part-tim yoy
full-tim job like expand
employee-sponsor plan membership
help off-set neg impact
congress effect remov
individu mandat
addit job gain expect robust wage
state tax revenu growth boost
 worker grew
yoy june mark strong
acceler averag growth
expect mani individu
util rise wage opt
comprehens health plan
provid tailwind sub-industri premium
strong state tax revenu growth
also tailwind
medicaid-focus firm whose contract
negoti state agenc like
see healthier budget higher tax
 manag
drop
year-to-d juli
manag health index
gain
base index
five-year market price perform jul
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
analyst research note compani news
manag care firm declin sharpli week driven least
partial five presidenti candid co-sponsor medicar bill
senat would elimin privat health plan assess whether bill
might impact futur earn industri review voter alreadi
choos government- privately-run health plan good place
start among senior medicar popul roughli opt privately-run
medicar advantag plan supplement tradit medicar privat benefit
medicaid estim enrolle privately-run plan add
estim peopl elig government-run health
care use privat option either person choos
elect offici state support government-run health care
mind believ bill elimin privat health plan little-to-no
chanc becom law /colin scarola
pm et cfra maintain strong buy opinion share
corpor drop target
conserv scenario estim normal ep fulli integr
wellcar wcg valuat histor forward price-to-earnings
averag due execut close risk high capit cost deal
includ equiti dilut ownership spike interest cost
like drive ep declin year ultim think deal
prove highli accret strateg purchas provid
technolog firm improv adjust medic cost ratio mcr
greatli outpac peer last three year mcr
bp wcg two year integr expect wcg membership
migrat lower mcr creat valu combin firm
far outweigh capit cost deal approv board
still subject approv sharehold regul mean failur
close remain risk view /colin scarola
et cfra maintain strong buy opinion share
corpor drop target
conserv estim normal ep wellcar wcg
acquisit assum close rais ep estim
ep vs beat
consensu expect oper metric continu improv
long term greater scale strateg invest cost
contain lower target reflect short-term polit headlin
think pressur manag care multipl oper revenu
yoy adjust pre-tax incom per share grew slower due
share count dilut fide acquisit deal year
gone growth lack boost still expect revenu growth
yoy though gener signific organ membership
premium growth accept medic cost especi marketplac plan
retent rate exceed forecast /colin scarola
pm et cfra maintain strong buy opinion share
corpor maintain ep estim
target price conserv scenario normal ep estim
plan wellcar wcg acquisit share
mid-day declar offici statement
make propos combin altern
centen propos transact wellcar statement
follow sever week rumor effort activist investor quash
-wcg deal instead buy welcom end
specul howev think patient investor see far greater
valu creation long-term on-going organ growth strategi
wcg purchas think signific valu creat bring
wcg medicaid member materi lower medic cost ratio
mcr year end march mcr adjust prior-period
reserv develop basi point better /colin scarola
pm et cfra rais sector overweight
marketweight cfra rais
sector overweight marketweight market valuat
expand sector trade discount histor averag cfra
find opportun within health care sector trade forward
price-to-earnings basi histor averag first quarter
compani health care sector beat sale
earn estim best perform index biotech
pharmaceut compani account market capit
sector drug pipelin approv time reduct activ make
industri attract care histori outperform
season slow period year may octob cfra
forecast sector like disappoint lindsey bell
pm et cfra maintain strong buy opinion share
corpor keep target
conserv scenario estim normal ep plan acquisit
wellcar wcg rais ep estim
keep ep vs beat consensu
oper revenu grew yoy driven membership growth yoy
strong price premium grew faster yoy growth driven
fide acquisit also achiev strong organ growth
quarter especi marketplac membership grew yoy
expand four new state medic cost ratio worsen
partial due moratorium health insur
fee partial off-set sg ratio improv bp yoy
aid cost synergi fide expect strong growth
driven medicaid win new mexico new hampshir iowa north carolina
well marketplac expans /colin scarola
pm et cfra keep buy opinion share
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
